Carter Bankshares, Inc. (CARE)
Data as of , from SEC Form 4 filings.
See up to 3 months of CARE. The 7-day demo opens the 1M and 3M ranges and puts CARE on your watchlist.
Start 7-day demoLatest CARE insider trades
About Carter Bankshares, Inc. (CARE)
Carter Bankshares, Inc. files with the SEC under CIK 0001829576 and is classified as national commercial banks. We track it alongside the rest of the Financials sector.
CARE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 5,000 | $169K |
| Bona-fide gift | 1 | 280 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CARE insider transactions (Form 4)
3939 Form 4 filings on record, the earliest from Jul 28, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Catharine L. Midkiff - Director | Open-market sale | Common Stock | 1,000 | $31.25 | $31K | |
| Gregory W. Feldmann - Director | Gift | Common Stock | 280 | $35.16 | $10K | |
| Robert M. Bolton - Director | Open-market sale | Common Stock | 1,500 | $34.60 | $52K | |
| Bradford N. Langs - Officer | Open-market sale | Common Stock | 2,500 | $34.54 | $86K | |
| Grant or award | Common Stock | 12,300 footnote F1 | $0.00 | - | ||
| ||||||
| Bradford N. Langs - Officer | Grant or award | Common Stock | 8,649 footnote F1 | $0.00 | - | |
| ||||||
| Arthur Loran Adams - Officer | Grant or award | Common Stock | 3,240 footnote F1 | $0.00 | - | |
| ||||||
| Matthew M. Speare - Officer | Grant or award | Common Stock | 5,005 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 3,604 footnote F1 | $0.00 | - | ||
| ||||||
| Wendy S. Bell - Officer | Grant or award | Common Stock | 6,428 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 5,472 footnote F1 | $0.00 | - | ||
| ||||||
| Tax withholding / forfeiture | Common Stock | 261 | $26.95 | $7K | ||
| Bradford N. Langs - Officer | Open-market sale | Common Stock | 5,500 | $26.47 | $146K | |
| Elizabeth L. Walsh - Director | Gift | Common Stock | 725 footnote F1 | $0.00 | - | |
| ||||||
| Elizabeth L. Walsh - Director | Open-market purchase | Common Stock | 4,575 | $26.20 | $120K | |
| James W. Haskins - Director | Open-market sale | Common Stock | 1,000 | $26.04 | $26K | |
| Grant or award | Common Stock | 1,850 footnote F1 | $0.00 | - | ||
| ||||||
| Arthur Loran Adams - Officer | Grant or award | Common Stock | 1,650 footnote F1 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 296 | $24.24 | $7K | ||
| Tax withholding / forfeiture | Common Stock | 819 | $20.98 | $17K | ||
| Bradford N. Langs - Officer | Tax withholding / forfeiture | Common Stock | 638 | $20.98 | $13K | |
| Matthew M. Speare - Officer | Tax withholding / forfeiture | Common Stock | 411 | $20.98 | $9K | |
| Wendy S. Bell - Officer | Tax withholding / forfeiture | Common Stock | 435 | $20.98 | $9K | |
| Tax withholding / forfeiture | Common Stock | 309 | $20.98 | $6K | ||
| Tax withholding / forfeiture | Common Stock | 351 | $22.01 | $8K | ||
| Grant or award | Common Stock | 2,023 footnote F1 | $0.00 | - | ||
| Grant or award | Common Stock | 2,335 footnote F2 | $0.00 | - | ||
| ||||||
| Wendy S. Bell - Officer | Tax withholding / forfeiture | Common Stock | 554 | $22.01 | $12K | |
| Wendy S. Bell - Officer | Grant or award | Common Stock | 2,513 footnote F1 | $0.00 | - | |
| Wendy S. Bell - Officer | Grant or award | Common Stock | 3,292 footnote F2 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 291 | $22.01 | $6K | ||
| Grant or award | Common Stock | 1,230 footnote F1 | $0.00 | - | ||
| ||||||
| Bradford N. Langs - Officer | Tax withholding / forfeiture | Common Stock | 781 | $22.01 | $17K | |
| Bradford N. Langs - Officer | Grant or award | Common Stock | 3,689 footnote F1 | $0.00 | - | |
| Bradford N. Langs - Officer | Grant or award | Common Stock | 4,428 footnote F2 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 1,158 | $22.01 | $25K | ||
| Grant or award | Common Stock | 4,870 footnote F1 | $0.00 | - | ||
| Grant or award | Common Stock | 7,198 footnote F2 | $0.00 | - | ||
| ||||||
| Arthur Loran Adams - Officer | Grant or award | Common Stock | 1,002 footnote F1 | $0.00 | - | |
| ||||||
CARE insider trading FAQ
What is the latest insider trade for CARE?
Carter Bankshares, Inc. (CARE) had 4 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for CARE runs to 39 Form 4 filings, the earliest from 2025-07-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CARE stock?
No insider purchases of CARE were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling CARE stock?
3 insider sales of CARE were filed in the last 90 days, totaling $169K.
Where can I see CARE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CARE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Financials companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Catharine L. Midkiff view on EDGAR
- - Gregory W. Feldmann view on EDGAR
- - Robert M. Bolton view on EDGAR
- - Bradford N. Langs view on EDGAR
- - Dyke Litz H. van view on EDGAR
- - Bradford N. Langs view on EDGAR
- - Arthur Loran Adams view on EDGAR
- - Matthew M. Speare view on EDGAR
- - Jane Ann Davis view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Financials
- Where CARE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CARE with a 7-day demo
- CARE on your watchlist
- Every CARE Form 4 filing on record
- Up to 3 months of CARE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive